(212)Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study

Multiple myeloma (MM) is a plasma cell cancer and represents the second most frequent hematologic malignancy. Despite new treatments and protocols, including high-dose chemotherapy associated with autologous stem cell transplantation, the prognosis of MM patients is still poor. α-radioimmunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Quelven, Isabelle, Monteil, Jacques, Sage, Magali, Saidi, Amal, Mounier, Jérémy, Bayout, Audrey, Garrier, Julie, Cogne, Michel, Durand-Panteix, Stéphanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2020
Materias:
Radionuclide Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383085/
https://www.ncbi.nlm.nih.gov/pubmed/31862796
http://dx.doi.org/10.2967/jnumed.119.239491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383085/
https://www.ncbi.nlm.nih.gov/pubmed/31862796
http://dx.doi.org/10.2967/jnumed.119.239491

Ejemplares similares